Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2627]

Depression and inflammation: A bad combo for lung cancer patients

Depression and inflammation: A bad combo for lung cancer patients

IGF2BP1: a critical driver of cancer progression and therapeutic target

IGF2BP1: a critical driver of cancer progression and therapeutic target

The role of fusion genes in cancer development and treatment

The role of fusion genes in cancer development and treatment

ImmunoCheckDB: A comprehensive web platform integrating meta-analysis and multiomic profiling to advance cancer immunotherapy biomarker discovery

ImmunoCheckDB: A comprehensive web platform integrating meta-analysis and multiomic profiling to advance cancer...

Perioperative toripalimab and chemotherapy in resectable non-small cell lung cancer: Another weapon in the armamentarium

Perioperative toripalimab and chemotherapy in resectable non-small cell lung cancer: Another weapon in the...

Rare non-small cell lung cancer with brain metastases responds to amivantamab monotherapy

Rare non-small cell lung cancer with brain metastases responds to amivantamab monotherapy

CHAF1B promotes the progression of lung squamous-cell carcinoma by inhibiting SETD7 expression

CHAF1B promotes the progression of lung squamous-cell carcinoma by inhibiting SETD7 expression

ASCO 2025: Ramucirumab and pembrolizumab combo does not improve OS for previously treated advanced NSCLC

ASCO 2025: Ramucirumab and pembrolizumab combo does not improve OS for previously treated advanced NSCLC

ASCO 2025: Nivolumab plus chemo before surgery improves lung cancer survival

ASCO 2025: Nivolumab plus chemo before surgery improves lung cancer survival

ASCO 2025: Molecular assay may help identify people with NSCLC who could benefit from adjuvant chemotherapy

ASCO 2025: Molecular assay may help identify people with NSCLC who could benefit from adjuvant chemotherapy

More from ecancer